HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severe bone marrow failure associated with the use of alternating steroid with chlorambucil in lupus membranous nephropathy in Chinese.

Abstract
Severe pancytopenia associated with the use of alternating steroid with chlorambucil regimen was described in six patients with nephrotic syndrome secondary to lupus membranous nephropathy (WHO class V). We believe this is the first report describing the life-threatening degree of marrow toxicity associated with this regimen of alternating steroid with chlorambucil in a Chinese population. Our data suggests that the susceptibility to marrow toxicity with the use of chlorambucil may only be applicable to Chinese patients with underlying systemic lupus erythematosus as a similar degree of toxicity has neither been reported in lupus patients of other ethnic groups nor in non-lupus patients of Chinese origin.
AuthorsA Y Wang, P K Li, F M Lai, K M Chow, C C Szeto, C B Leung, S F Lui
JournalLupus (Lupus) Vol. 10 Issue 4 Pg. 295-8 ( 2001) ISSN: 0961-2033 [Print] England
PMID11341107 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents, Alkylating
  • Steroids
  • Chlorambucil
Topics
  • Adult
  • Antineoplastic Agents, Alkylating (adverse effects, therapeutic use)
  • Bone Marrow (drug effects, immunology)
  • Bone Marrow Diseases (chemically induced, immunology, physiopathology)
  • China
  • Chlorambucil (adverse effects, therapeutic use)
  • Female
  • Humans
  • Lupus Nephritis (drug therapy, immunology, physiopathology)
  • Male
  • Steroids (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: